Government Pharmaceutical Organization signed a cooperation agreement with Korea. Transferring inactivated influenza vaccine technology for type 3 and 4 strains from cell culture hopes to help improve the quality of life of the people The reason for choosing Thai because of its potential and good production location
Dr. Opas Karnkawinpong Permanent Secretary of the Ministry of Public Health Presided over the signing of cooperation between Dr. Mingkwan Suphanpong, Director of the Government Pharmaceutical Organization and Mr.Ahn Jae Yong, CEO of SK bioscience Co.,Ltd in the production of influenza vaccines from cell cultures. for national and regional vaccine security The details of the development of the vaccine will be produced from inactivated cell cultures for 3 and 4 strains in the form of ready-to-pack vaccines. and transfer of packaging technology for the production of ready-made vaccines Use the premises of the Government Pharmaceutical Organization to set up a manufacturing plant. It is expected that the prototype vaccine production process will be completed in 1-2 years and in the future there may be research on shingles vaccine production.
Mr.Ahn Jae Yong said that for choosing Thailand to develop production cooperation because of the relationship between Thailand and Korea. In addition, the readiness of the Pharmaceutical Organization and believes that at the government level it is ready to support to improve the quality of life of the people And in the future, this production facility will also be the center of Southeast Asia.-Thai News Agency
Source: Thai News Agency